Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02241343
NCT02241343TerminatedNot Applicable

Venous Occlusion and Limb Swelling

Imperial College London2 sites in 1 country1 target enrollmentStarted: May 2014Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
1
Locations
2
Primary Endpoint
Leg Swelling
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Problems affecting the veins in the legs can cause discomfort and swelling. We want to see how artificially and reversibly blocking the leg veins affects swelling in the lower limb.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Over 18 years old, able to consent

Exclusion Criteria

  • •History of cardiovascular/renal disease

Outcomes

Primary Outcomes

Leg Swelling

Time Frame: 30 minutes

Perometer measured leg volume from footplate to middle of knee joint (in standing position; ml)

Secondary Outcomes

  • Venous Diameter(30 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Recruiting
Not Applicable
The Venous Distension Reflex and Orthostatic HypertensionBlood Pressure
NCT03496792Milton S. Hershey Medical Center30
Completed
Phase 3
Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) IncompetenceVaricose Veins
NCT01072877Boston Scientific Corporation279
Completed
Phase 3
Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) IncompetenceVaricose Veins
NCT01231373Boston Scientific Corporation235
Completed
Phase 1
Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM)Varicose Veins
NCT01428076Boston Scientific Corporation21
Completed
Phase 3
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible VaricositiesGreat Saphenous Vein IncompetenceVisible Varicosities
NCT01197833Boston Scientific Corporation117
Venous Occlusion and Limb Swelling | Clinical Trial